Published in Lancet on July 07, 1990
Postgraduate training in Italy. Lancet (1990) 0.75
Efficacy of epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen. Haematologica (1999) 2.06
Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol (2000) 2.05
Intensified chemotherapy with stem-cell rescue in germ-cell tumors. Ann Oncol (2011) 1.48
Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: a new sensitive one step method without false positive results. Bone Marrow Transplant (1998) 1.44
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Ann Oncol (2006) 1.21
Fulvestrant for advanced male breast cancer patients: a case series. Ann Oncol (2011) 1.04
Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res (1999) 1.01
Mitomycin C as an alternative to irradiation to inhibit the feeder layer growth in long-term culture assays. Cytotherapy (2000) 0.92
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study. Br J Cancer (2006) 0.91
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results. Ann Oncol (2011) 0.90
Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood (1997) 0.89
Toxicity and clinical tolerance of lonidamine. Semin Oncol (1991) 0.89
Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia (1994) 0.84
Effects of recombinant human H-subunit and L-subunit ferritins on in vitro growth of human granulocyte-monocyte progenitors. Br J Haematol (1988) 0.84
Meningeal carcinomatosis in rectal cancer. Clin Oncol (R Coll Radiol) (2002) 0.81
T cell therapy for nasopharyngeal carcinoma. J Cancer (2011) 0.81
Effect of recombinant human erythropoietin on hematopoietic and non-hematopoietic malignant cell growth in vitro. Haematologica (1994) 0.81
Transfusion requirement can be abolished by epoietin-a and autologous platelet predeposit in patients receiving high dose chemotherapy with stem cell support. Haematologica (2000) 0.80
"Stem cell candidates" purified by liquid culture in the presence of Steel factor, IL-3, and 5FU are strictly stroma-dependent and have myeloid, lymphoid, and megakaryocytic potential. Exp Hematol (1997) 0.80
Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry. Bone Marrow Transplant (2012) 0.80
Progression from nodular to lymphangitic subcutaneous metastasis from clear cell endometrial carcinoma: CT findings. Tumori (1998) 0.80
Proliferative effect of dexamethasone on a human glioblastoma cell line (HU 197) is mediated by glucocorticoid receptors. Anticancer Res (1992) 0.80
Late onset of gallbladder carcinoma with meningeal carcinomatosis. Eur J Cancer (1992) 0.79
Cerebrospinal fluid ferritin in human disease. Haematologica (1986) 0.79
Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer. Anticancer Res (1995) 0.79
Recombinant human G-CSF: how wide is the field of clinical applicability? Haematologica (1995) 0.78
Antitumor effect of allogeneic hematopoietic SCT in metastatic medulloblastoma. Bone Marrow Transplant (2008) 0.77
GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia. Cytotherapy (2007) 0.77
Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. Bone Marrow Transplant (1994) 0.77
CG5/Dx human breast cancer cell line: characterization of a new doxorubicin-resistant variant. Anticancer Res (1996) 0.76
Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors. Ann Oncol (2003) 0.76
Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia (1989) 0.76
Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors. Am J Hematol (1993) 0.76
Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donors. Haematologica (1996) 0.76
Re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. J Natl Cancer Inst (2000) 0.75
Myeloprotective effect of medroxyprogesterone acetate (MPA) Eur J Cancer (1993) 0.75
Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia. Haematologica (1992) 0.75
High-dose chemotherapy and stem-cell support in breast cancer. Lancet (1998) 0.75
Transplantation of peripheral blood stem cells mobilized by haematopoietic growth factors in childhood. Bone Marrow Transplant (1998) 0.75
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies. Biol Blood Marrow Transplant (2005) 0.75
c-myc and c-myb oncoproteins during induced maturation of human myeloid and erythroid leukaemic lines. Haematol Blood Transfus (1989) 0.75
[Splenic metastases of ovarian carcinoma]. Minerva Chir (1993) 0.75
Sustained remission of immune-mediated red cell aplasia in a child after intravenous administration of gamma globulin. J Pediatr (1994) 0.75
[Evaluation of the intestinal absorption of iron orally administered as chondroitin sulfate in normal subjects]. Minerva Med (1989) 0.75
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL). Haematologica (1986) 0.75
A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation. Bone Marrow Transplant (1997) 0.75
Establishment and characterization of two cell lines derived from human glioblastoma multiforme. Anticancer Res (1992) 0.75
Costs of autologous stem-cell transplantation in solid tumours. Ann Oncol (2001) 0.75
Toxic epidermal necrolysis following Yersinia enterocolitica infection. Int J Dermatol (1993) 0.75
Successful allogeneic bone marrow transplantation in a child affected by Fanconi anemia. Bone Marrow Transplant (1991) 0.75
Screening of humoral suppression of in vitro granulopoiesis by means of serum inhibitor assay for CFU-GM. Boll Soc Ital Biol Sper (1985) 0.75
In vitro and in vivo effects of recombinant interferon gamma on the growth of hematopoietic progenitor cells from patients with myelodysplastic syndrome. Haematologica (1990) 0.75
Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatment. Anticancer Res (1999) 0.75
Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: comparison with sister chromatid exchange frequency. Int Arch Occup Environ Health (1999) 0.75
"In vitro" action of intact gamma-globulin on granulopoiesis: modulation of GM-CSA production. Boll Soc Ital Biol Sper (1985) 0.75
[Biological screening of immuno-mediated marrow insufficiency by means of the CFU-GM assay]. Boll Soc Ital Biol Sper (1984) 0.75
Cell- and humoral-mediated granulopoietic failure detected by CFU-GM assay in one case of Felty's syndrome unresponsive to prednisolone treatment. Haematologica (1986) 0.75
Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation. Med Pediatr Oncol (1995) 0.75
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons]. Haematologica (1991) 0.75
Lymphoproliferative disorder of large granular lymphocytes: reversal of lymphocyte proliferation, anemia and neutropenia with chlorambucil. Tumori (1987) 0.75
In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes. Haematologica (1989) 0.75
Pulmonary function and complications following chemotherapy and stem cell support in breast cancer. Eur Respir J (2000) 0.75
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure. Haematologica (1986) 0.75
Clinical results in 2001 show high dose therapy and hematopoietic progenitor cell transplantation as a therapeutic option for breast cancer. Haematologica (2001) 0.75
Tumor necrosis factor alpha down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia. Leukemia (1990) 0.75
Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more effective than G-CSF alone in mobilizing hemopoietic progenitor cells in severe, refractory rheumatoid arthritis. Haematologica (2001) 0.75
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells. Haematologica (1988) 0.75
Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation. Br J Haematol (1992) 0.75
Evidence of graft-versus-tumour effect following allogeneic haematopoietic stem cell transplantation in renal cancer other than clear cell type. Bone Marrow Transplant (2004) 0.75
Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia. Haematologica (1993) 0.75
Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell line. Anticancer Res (1994) 0.75
Autologous CD133+ cells augment the effect of portal embolization. Minerva Chir (2013) 0.75
Splenic metastases in patients with portal hypertension. Eur J Cancer (1995) 0.75
Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syndromes. Leukemia (1988) 0.75
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. Br J Haematol (1991) 0.75